Riabni

Indicated For

CLL, NHL, RA

About This Medication

# Amgen Safety Net Foundation Patient Guide: How to Get Riabni (rituximab-arrx) at Low or No Cost Riabni (rituximab-arrx) is a biosimilar to Rituxan (rituximab), used to treat conditions like certain lymphomas, leukemias, rheumatoid arthritis, and other autoimmune diseases. The **Amgen Safety Net Foundation** provides this medication at no cost to qualifying uninsured or underinsured patients in the US and Puerto Rico who demonstrate financial need.[1][2] ## About Riabni (rituximab-arrx) **Riabni** is an injectable biosimilar monoclonal antibody that targets CD20 on B-cells, helping to treat cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune conditions like rheumatoid arthritis (when combined with methotrexate) and granulomatosis with polyangiitis. It works similarly to the reference product Rituxan but is produced by Amgen, often at a lower cost. Administered by healthcare professionals via IV infusion, typical courses involve multiple doses over weeks or months, depending on your doctor's prescription. Always follow your healthcare provider's instructions, as side effects can include infusion reactions, infections, or low blood cell counts. This program helps remove financial barriers so you can focus on your health.[1] ## Who Qualifies for the Program? The Amgen Safety Net Foundation is designed for patients facing financial challenges with Amgen medications like Riabni. Key eligibility factors include: - **Residency**: Must live in the US or Puerto Rico.[1] - **Financial Need**: Demonstrate inability to afford the medicine. Specific income thresholds are based on nonprofit criteria—call (866) 264-2778 for personalized details, as exact FPL percentages aren't publicly listed.[1] - **Insurance Status**: Uninsured or underinsured patients, including those with Medicare Part D if the plan excludes Riabni or out-of-pocket costs are unaffordable. You must not be eligible for Medicaid or Medicare's Low-Income Subsidy (Extra Help).[1][2] - **Other Requirements**: Satisfy payer guidelines, prior authorizations (PA), and have no other financial support options. Enrollment is needs-based; coverage isn't required.[1] This patient-friendly program prioritizes access for those without adequate insurance, ensuring essential treatments like Riabni reach those in need.[1] ## Income Eligibility Breakdown Income eligibility follows nonprofit guidelines, often aligned with federal poverty levels (FPL) but customized. Exact thresholds (e.g., 400-500% FPL) vary; contact the program for your situation. Here's a general table based on common patient assistance patterns—verify by phone: | Household Size | Estimated Max Annual Income (300% FPL example)* | Notes | |---------------|------------------------------------------------|-------| | 1 (Individual) | ~$45,180 | Call for exact nonprofit criteria[1] | | 2 (Couple) | ~$61,320 | Adjusts for dependents[1] | | 3 | ~$77,460 | Includes all household income[1] | | 4 | ~$93,600 | Higher for larger families[1] | *Examples for 2026; actuals may be higher (e.g., up to 500%+ FPL). Provide proof like tax returns. Program supports underinsured Medicare patients unable to afford copays.[1][2] ## Insurance Requirements - **Uninsured**: Fully eligible if you meet financial criteria.[1] - **Underinsured**: Includes Medicare Part D patients whose plan excludes Riabni/biosimilars or where costs are unaffordable. Must: 1. Prove inability to pay. 2. Not qualify for Medicaid/Extra Help. 3. Meet PA requirements. 4. Lack other aid.[1] - **Medicare/Medicaid**: Ineligible if on Medicaid or Extra Help. Underinsured Medicare patients may qualify if coverage gaps exist.[1] No insurance? You're a prime candidate. The program ships free medication directly to you.[1][2] ## Step-by-Step Application Process Applying is straightforward—start by phone, then complete forms. Here's how: 1. **Contact Amgen Assist**: Call **(866) 264-2778** (Mon-Fri, 9 a.m.-8 p.m. ET) for new applicants to screen eligibility. Current patients get HCP notifications.[1] 2. **Complete Patient Application**: Fill pages 1-4 with personal details, household income, insurance info, and financial hardship proof.[2] 3. **Physician Prescription**: Have your doctor complete page 5 (prescription for Riabni).[2] 4. **Gather Documents**: Include income verification (e.g., tax returns, pay stubs), insurance details, and PA if needed. Exact list confirmed by phone.[1][2] 5. **Submit**: Fax to 1-833-959-1409 or follow phone instructions. Alternatively, call 1-800-932-3060 for guidance. Keep copies![2] 6. **Follow Up**: Program contacts you/HCP on status. For currently enrolled: HCP gets renewal notice; re-verify eligibility.[1] ## Timeline and Delivery Processing time varies (typically 2-4 weeks, but call for updates). Once approved, Riabni ships **directly to your home** or doctor's office—free of charge. Expect notifications via mail/HCP. Refills/reauthorizations follow similar steps; stay in touch to avoid gaps.[1][2] ## Alternatives if Denied - **Appeal**: Contact (866) 264-2778 to discuss reasons and resubmit.[1] - **Biosimilar Alternative**: Rituxan (rituximab)—same foundation may cover if eligible.[1] - **Other Programs**: Check NeedyMeds, PAN Foundation, or state assistance. For Medicare, explore Extra Help application. Generic/biosimilar options via your pharmacy benefit.[1] - **Manufacturer Support**: Amgen Assist offers copay cards for commercially insured (separate from Safety Net).[1] ## Important Disclaimer This guide is for informational purposes based on available program details as of 2026. Eligibility, terms, and forms can change—**always verify directly with Amgen Safety Net Foundation at (866) 264-2778**. Not medical/financial advice; consult your doctor and advisor. Amgen doesn't guarantee approval. Program for US/Puerto Rico residents only.[1][2]

Program information last verified: March 30, 2026